Generated Narrative: Evidence 557366 version: 1; Last updated: 2026-04-08 13:56:39+0000 Profile: ComparatorOnlyEvidence ArtifactPublicationStatus: Active url: https://fevir.net/resources/Evidence/557366 identifier: FEvIR Object Identifier/557366, outcomeId/313963, picoId/85798, sectionId/73215 name: Serious_hyperglycaemia_Comparator_Evidence_from_MAGICapp_313963 title: MAGIC-derived ComparatorOnlyEvidence: Serious hyperglycaemia in GLP-1 RA Group in Adults with type 2 diabetes citeAs: MAGIC-derived ComparatorOnlyEvidence: Serious hyperglycaemia in GLP-1 RA Group in Adults with type 2 diabetes [Database Entry: FHIR Evidence Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 557366. Revised 2026-04-08. Available at: https://fevir.net/resources/Evidence/557366. Computable resource at: https://fevir.net/resources/Evidence/557366#json. status: Active author: Computable Publishing®: MAGIC-to-FEvIR Converter: publisher: Computable Publishing LLC contact: support@computablepublishing.com UseContexts - Code Value[x] * Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication (Evidence Communication) ComparatorOnlyEvidence copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/ RelatesTos - Type Target[x] * Part Of MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report) description: This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide. note: Data from the placebo arm in included trials (median). variableDefinition description: Adults with type 2 diabetes -- GLP-1 RA variableRole: Population observed: GLP-1 RA Group in Adults with type 2 diabetes variableDefinition description: Serious hyperglycaemia variableRole: Outcome observed: Serious hyperglycaemia synthesisType: NOTSET studyDesign: COMPARATOR_ARM Statistics - Description StatisticType Quantity * Risk 1.0% proportion 0.01
MAGIC-derived ComparatorOnlyEvidence: Serious hyperglycaemia in GLP-1 RA Group in Adults with type 2 diabetes
MAGIC-derived ComparatorOnlyEvidence: Serious hyperglycaemia in GLP-1 RA Group in Adults with type 2 diabetes [Database Entry: FHIR Evidence Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 557366. Revised 2026-04-08. Available at: https://fevir.net/resources/Evidence/557366. Computable resource at: https://fevir.net/resources/Evidence/557366#json.
Computable Publishing®: MAGIC-to-FEvIR Converter
MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes
This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.
Data from the placebo arm in included trials (median).
GLP-1 RA Group in Adults with type 2 diabetes